Breast Cancer Session
Lung Cancer Session
Oncology Nursing Session
Uro-Oncology Session
Palliative Care Session

Breast Cancer

08:40 – 08:45

Opening Remarks
Sudeep Gupta , India | Shona Nag, India

08:45 – 09:05

Management of Febrile Neutropenia – Clinical Cases – Supported By Kyowa Kirin
Sonia Otsmane, United Arab Emirates

09:05 – 10:25

Breast Cancer Session 1
Rham Zaki Ahmed, United Arab Emirates | Syed Nayyar Raza, United Arab Emirates

09:05 – 09:25

Key Highlights in the MONALEESA Program
Peter Fasching, Germany

09:25 – 09:45

Session 1 : A Year in Review : Putting Important Data into Perspective
Stephen Johnston, United Kingdom

09:45 – 10:05

Session 1 : Managing Metastatic HER2 Positive Breast Cancer in 2021
Javier Cortes, Spain

10:05 – 10:25

Session 1 : Panel Discussion on HER2 Positive Breast Cancer
Hamdy Abdul Azim, Egypt | Bhawana Sirohi, India | Stephen Johnston, United Kingdom | Giuseppe Curigliano, Spain | Javier Cortes, Spain | Mohsen Mokhtar, Egypt | Diaeddine Ahmad Trad, United Arab Emirates | Fathi Al Azribi, United Arab Emirates | Dalia Elshorbagy, United Arab Emirates | Mouza Al-Ameri, United Arab Emirates

10:40 – 12:05

Breast Cancer Session 2
Aydah Mohammed Saleh Al Awadhi, United Arab Emirates | Millicent Bello, United Arab Emirates | Sonia Otsmane, United Arab Emirates

10:40 – 11:00

Optimizing Endocrine Therapy ER+ mBC – Supported By Lilly
Mark Verrill, United Kingdom

11:00 – 11:15

Session 2 : Adjuvant Endocrine Therapy in 2021: Challenges and Questions?
Mohsen Mokhtar, Egypt

11:15 – 11:30

Session 2 : How to Approach a Patient with BRCA Positive Breast Cancer in the Early Stage Setting?
Nita Nair, India

11:30 – 11:45

Session 2 : SNB is a Reasonable Option for Patients with an Initially Positive Axilla Responding to Neoadjuvant Therapy
Ahmad Matalkah, United Arab Emirates

11:45 – 12:05

Latest Data Impacting Guidelines in HR +ve/HER2 -ve aBC – Supported By Novartis
Nagi El-Saghir, Lebanon

13:25 – 15:15

Breast Cancer Session 3
Archana Shetty, United Arab Emirates | Nagi El-Saghir, Lebanon | Mouza Al-Ameri, United Arab Emirates

13:25 – 13:40

Session 3 : Descalation Strategies in Breast Cancer: Where are we and Where we want to be?
Antonio Llombart, Spain

13:40 – 13:55

Session 3 : Novel Drugs and Antibody Drug Conjugates: What the Future holds for Breast Cancer
Giuseppe Curigliano, Spain

13:55 – 14:10

Session 3 : Incorporating Molecular Testing in the Management of Breast Cancer – When, for Whom and How?
Nitesh Rohatgi, India

14:10 – 14:30

Role of gBRCA Mutations in the Management of eBC Patients – Supported By AstraZeneca
Shaheenah Dawood, United Arab Emirates

14:30 – 14:50

Genetic Tests on Solid Tumor using Next Generation Sequencing in Clinical Laboratory – Supported By Purehealth
Hyo Jin Park, United Arab Emirates

14:50 – 15:10

Session 3 : Panel discussion: Triple Negative Breast Cancer
Shona Nag, India | Mohsen Mokhtar, Egypt | Nitesh Rohatgi, India | Mohanad Diab, United Arab Emirates | Sudeep Gupta , India | Giuseppe Curigliano, Spain | Sonia Otsmane, United Arab Emirates | Diaeddine Ahmad Trad, United Arab Emirates | Nouri Bennini, United Arab Emirates | Antonio Llombart, Spain

15:10 – 15:15

Closing Remarks
Shona Nag, India
 

Lung Cancer

08:30 – 10:20

Lung Cancer Session 1
Kaltar Das, United Arab Emirates | Falah Al Khatib, United Arab Emirates | Syed Nayyar Raza, United Arab Emirates

08:30 – 08:35

Introduction
Prabhash Kumar, India

08:35 – 08:55

Is it Time to Adopt a “Blood First” approach in NSCLC – Supported by New Bridge
Natasha Leighl, Canada

08:55 – 09:10

Session 1 : Molecular Profiling of Lung Cancer in CLINIC – What is Optimal and What is Maximum?
Ben Solomon, Australia

09:10 – 09:25

Session 1 : Adjuvant Therapy in Non-Small Cell Lung cancer – Beyond Chemotherapy
Ramaswamy Govindan, USA

09:25 – 09:40

Session 1 : Locally Advanced NSCLC – Does Every Patient needs Immunotherapy?
Riyaz  Shah, United Kingdom

09:40 – 10:20

Session 1 : Panel Discussion
Prabhash Kumar, India | Ben Solomon, Australia | Ramaswamy Govindan, USA | Vivek Subbiah, USA | Maroun El Khoury, United Arab Emirates | Nitesh Rohatgi, India | Vanita Noronha, India | Abhishek Mahajan, India | Nouri Bennini, United Arab Emirates | Syed Nayyar Raza, United Arab Emirates

10:35 – 10:55

Session 1 : Immunotherapy – How to Choose the Right Patient for Right Treatment in Advanced Non-Small Cell Lung Cancer
Solange Peters, Switzerland

10:55 – 11:05

Session 1 : 4-year update from CheckMate 227
Solange Peters, Switzerland

11:05 – 11:15

Session 1 : 3-year update from CheckMate 743
Solange Peters, Switzerland

11:15 – 11:35

EGFR Talks: How to Optimize EGFR mut+ NSCLC Treatment – Supported by Lilly
Silvia Novello, Italy

11:35 – 12:25

lung Cancer Session 2
Dalia Elshorbagy, United Arab Emirates | Sonia Otsmane, United Arab Emirates

11:35 – 11:50

Session 2 : Proteogenomic Alterations in Lung Cancer
Ramaswamy Govindan, USA

11:50 – 12:05

Session 2 : EGFR Mutation Positive Advanced Lung Cancer – Are Newer Options Similar?
Tony Mok, Hong Kong

12:05 – 12:25

Revolution of Adjuvant Treatment in the EGFRm NSCLC – Supported by AstraZeneca
Tony Mok, Hong Kong

13:25 – 16:10

Lung Cancer Session 3
Mohanad Diab, United Arab Emirates | Emad Anwar Dawoud, United Arab Emirates | Nouri Bennini, United Arab Emirates

13:25 – 13:40

Session 3 : Management of Mutation Positive NSCLC – Beyond EGFR, ALK, ROS1
Vivek Subbiah, USA

13:40 – 14:00

Long Term Outcomes with Checkpoint Inhibitors in NSCLC – Supported By MSD
Emad Anwar Dawoud, United Arab Emirates

14:00 – 14:20

Transforming the Undruggable NSCLC Targets – Supported by Amgen
Jawaher Ansari, United Arab Emirates

14:20 – 14:30

Session 3 : Small Cell Lung Cancer – How Much is the Real Gain
Nitesh Rohatgi, India

14:30 – 14:40

Session 3 : Geriatric Lung Cancer – Do we Need to Manage Differently?
Vanita Noronha, India

14:40 – 14:55

Session 3 : Molecular Profile of Lung Cancer – Asian Perspective
‪Pratik Chandrani, India

14:55 – 15:25

Dual Immunotherapy Approach in 1L NSCLS Treatment – Supported By BMS
Aref Chehal, United Arab Emirates

15:25 – 16:05

Session 3 : Panel Discussion
Ullas Batra, India | Tony Mok, Hong Kong | Vivek Subbiah, USA | Prabhash Kumar, India | Solange Peters, Switzerland | Riyaz  Shah, United Kingdom | Kaltar Das, United Arab Emirates | Emad Anwar Dawoud, United Arab Emirates | Nitesh Rohatgi, India | Aref Chehal, United Arab Emirates

16:05 – 16:10

Closing Remarks
Prabhash Kumar, India
 

Oncology Nursing Session

09:00 – 12:25

Oncology Nursing Session
Khaled Al Qawasmeh, United Arab Emirates

09:00 – 09:25

Focusing on the Basics in Oncology Nursing
Rosemary Wasti, United Arab Emirates

09:25 – 09:50

Starting from the Beginning as a Breast Care Nurse in the UAE
Paige O’Malley, United Arab Emirates

09:50 – 10:15

Patient Care and Nursing Consideration in Autologous Stem Cell Transplant
Sadiya Abdulle, United Arab Emirates

10:15 – 10:40

The Arte and Science of Nursing Research
Tahani Al Dweikat, USA

10:55 – 11:20

Managing Pain in Palliative Care: A Ladder to Success
Luke Ebrahim, United Arab Emirates

11:20 – 11:45

Care and Maintenance of Central Venous Access Devices
Katherine Thomas, United Arab Emirates

11:45 – 12:15

Oncology Nursing Q&A

12:15 – 12:25

Closing Remarks
Khaled Al Qawasmeh, United Arab Emirates
 

Uro Oncology

13:30 – 13:35

Welcome Note
Abdulqadir Alzarooni, United Arab Emirates

13:30 – 14:50

Session 1: Updates on Urothelial Cancer
Abdulqadir Alzarooni, United Arab Emirates | Yasser Farahat, United Arab Emirates | Ayman Younis, United Arab Emirates | Ali Thwaini, United Arab Emirates

13:35 – 13:40

Update on EUS-OS, AAU and EUSC Annual Meeting
Yasser Farahat, United Arab Emirates

13:40 – 13:55

Techniques in Bladder Tumour Resection
Ahmed Ali, United Kingdom

13:55 – 14:10

NMIBC – Updates in Management; Impact of COVID on Follow Up
Omer Al Darwish, United Arab Emirates

14:10 – 14:25

Kidney – Sparing Surgery (KSS) in Upper Tract Urothelial Cancer (UTUC)
Mudhar Hassan, United Arab Emirates

14:25 – 14:40

Surgical Management of MIBC – Will the Robot Replace Convention?
Nikhil Vasdev, United Kingdom

14:40 – 14:50

Panel Discussion and Q&A

14:50 – 16:45

Session 2: Renal Cancer
Ali Thwaini, United Arab Emirates | Mohsen El Mekresh, United Arab Emirates | Yaser Saeedi, United Arab Emirates

14:50 – 15:10

Evolution of Advanced Renal Cell Carcinoma (aRCC) Treatment – Supported by Ipsen
Jens Bedke, Germany | Jawaher Ansari, United Arab Emirates

15:10 – 15:25

Updates on the Management of Small Renal Masses
Mohammad Abufaraj, Jordan

15:25 – 15:40

Role of Surgery in Metastatic Renal Cancer: Is there still a Role?
Motaz Melhem, United Kingdom

15:40 – 15:55

Nephron-Sparing Surgery: Tips, Tricks and Techniques
Rabii Madi, United Arab Emirates

15:55 – 16:10

Tumour Bearing Kidneys as Potential Organ Donors (TAPER): A Concept
Ali Thwaini, United Arab Emirates

16:10 – 16:35

Navigating Through 1L IO based Treatment Options for Advanced RCC – Supported by BMS
Jawaher Ansari, United Arab Emirates

16:35 – 16:45

Panel Discussion and Q&A

16:55 – 17:10

Updates in Systemic Management of Prostate Cancer
Suneil Jain, United Kingdom

16:55 – 18:00

Session 3: Prostate Cancer
Ali Thwaini, United Arab Emirates | Ahmed Ali, United Kingdom | Ammar Hameed, United Kingdom

17:10 – 17:30

Management of mHSPC: Updates from TITAN final analysis : – Supported By Jansen
Emad Anwar Dawoud, United Arab Emirates

17:30 – 17:45

Proton Therapy for High Risk Prostate Case – Supported By Apollo

17:45 – 18:00

Panel Discussion, Q&A and Closing Remarks
Waleed Hassen, United Arab Emirates | Ammar Hameed, United Kingdom
 

Palliative Care

13:30 – 13:45

Welcome & Introductions with Music
Mona Tareen, United Arab Emirates

13:45 – 14:30

Facing Death: Palliative Care and the Final Stage of Life
Robert Zalenski, USA

14:30 – 15:15

Panel Discussion: Goals of Care Decisions by Hospitalized Patients – Missed Opportunities & Barriers
Mona Tareen, United Arab Emirates | Katie Sweeting, United Arab Emirates | Kayane Mheidly, United Arab Emirates | Neil Arun Nijhawan, United Arab Emirates | Robert Zalenski, USA | Julieta Zuluaga, United Arab Emirates | Jamshed Khan, United Arab Emirates | Zafar Javed, United Arab Emirates

15:15 – 15:40

Pain Management and Best Practices for Opioid Rotation
Mona Tareen, United Arab Emirates

15:40 – 16:05

Breakthroughs in Cancer Pain Management – Supported By NewBridge

16:20 – 16:50

Palliative Care Emergencies
Katie Sweeting, United Arab Emirates

16:50 – 17:15

Role of Transfusions in End Stage Leukemia
Julieta Zuluaga, United Arab Emirates

17:15 – 17:25

Closing Remarks
Mona Tareen, United Arab Emirates